A Case of Prurigo Nodularis Treated with Dupilumab / 대한피부과학회지
Korean Journal of Dermatology
; : 687-691, 2022.
Artigo
em Inglês
| WPRIM (Pacífico Ocidental)
| ID: wpr-968043
Biblioteca responsável:
WPRO
ABSTRACT
Prurigo nodularis (PN) is a chronic inflammatory skin disease characterized by multiple nodules and papules, which are accompanied by intense pruritus. Treatment is challenging and requires a diverse approach. Recently, a few reports have described successful treatment of PN with dupilumab. We report a case of a patient with treatment-resistant PN who was successfully treated with dupilumab. Dupilumab was administered at the standard dose an initial induction dose of 600 mg, followed by 300 mg every 14 days. Pruritus reduced after 2 weeks and almost completely disappeared after 4 weeks of treatment.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Idioma:
Inglês
Revista:
Korean Journal of Dermatology
Ano de publicação:
2022
Tipo de documento:
Artigo